ZGN-433

DRUG2 trials

Sponsors

Zafgen, Inc.

Conditions

Obesity

Phase 1

Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers

CompletedNCT01028261

Zafgen, Inc.Obesity

Start: 2009-12-31End: 2010-10-31Updated: 2012-01-11

Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers

CompletedNCT01372761

Zafgen, Inc.Obesity

Start: 2011-06-30End: 2011-11-30Updated: 2011-12-30